Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to Nexiguran Ziclumeran for the Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
YOVIX Fund | USD 16.75 0.10 0.60% |
Slightly above 52% of Yorktown Small-cap's investor base is interested to short. The analysis of overall sentiment of trading Yorktown Small Cap Fund mutual fund suggests that many investors are impartial at this time. Yorktown Small-cap's investing sentiment can be driven by a variety of factors including economic data, Yorktown Small-cap's earnings reports, geopolitical events, and overall market trends.
Yorktown |
CAMBRIDGE, Mass, Nov. 25, 2024 -- Intellia Therapeutics, Inc. , a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to nexiguran ziclumeran for the treatment of hereditary transthyretin amyloidosis with polyneuropathy . Nex-z
Read at finance.yahoo.com
Yorktown Small-cap Fundamental Analysis
We analyze Yorktown Small-cap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yorktown Small-cap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yorktown Small-cap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Yorktown Small is rated third in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Yorktown Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Yorktown Small-cap mutual fund to make a market-neutral strategy. Peer analysis of Yorktown Small-cap could also be used in its relative valuation, which is a method of valuing Yorktown Small-cap by comparing valuation metrics with similar companies.
Peers
Yorktown Small-cap Related Equities
YOVAX | Yorktown Small-cap | 0.61 | ||||
YOVIX | Yorktown Small-cap | 0.60 | ||||
YOVLX | Yorktown Small-cap | 0.59 | ||||
APIBX | Api Short | 0.49 | ||||
APGRX | Api Growth | 0.39 | ||||
APITX | Api Growth | 0.31 | ||||
APIMX | Api Short | 0.26 | ||||
APIUX | Api Multi | 0.24 | ||||
AFFIX | Api Multi-asset | 0.13 | ||||
APIIX | Api Multi | 0.11 |
Other Information on Investing in Yorktown Mutual Fund
Yorktown Small-cap financial ratios help investors to determine whether Yorktown Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yorktown with respect to the benefits of owning Yorktown Small-cap security.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |